The cystic fibrosis therapeutics market is expected to grow from an estimated USD 10.52 billion in 2024 to USD 37.60 billion in 2033, at a CAGR of 15.20%. The therapeutics market for cystic fibrosis has been growing rapidly due to the emergence of targeted drugs, raising awareness among patients, and supportive policies by regulatory bodies. Through CFTR modulators, a direct action on the...